← back to search

Inmaculada Martinez‐Saguer

National Hemophilia Foundation ·
Area of research
Genetics · Hematology
Research interest
Research interests include Coagulation, Bradykinin, Polyphosphates, and Angioedema, Hemophilia Treatment and Research, Complement system in diseases, and Urticaria and Related Conditions.
h-index
29
citations
3,664
works
100
NIH funding
primary concept
email

Recent publications

Lanadelumab’s impact on hereditary angioedema control and quality of life across disease activity subgroups
Annals of Allergy Asthma & Immunology 2025cited by 9position: lastdoi
Long-Term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label Extension
The Journal of Allergy and Clinical Immunology In Practice 2025cited by 3position: middledoi
Sebetralstat for On‐Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT‐S
Clinical and Translational Allergy 2025cited by 1position: middledoi
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
The Lancet 2023cited by 47position: middledoi
Patients with hereditary angioedema and their treatment patterns in Germany: a Delphi consensus study
European Journal of Dermatology 2022cited by 5position: firstdoi
Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
Allergy 2021cited by 98position: middledoi
Consensus on treatment goals in hereditary angioedema: A global Delphi initiative
Journal of Allergy and Clinical Immunology 2021cited by 66position: middledoi
Validation of the Angioedema Control Test (AECT)—A Patient-Reported Outcome Instrument for Assessing Angioedema Control
The Journal of Allergy and Clinical Immunology In Practice 2020cited by 122position: middledoi
Definition, aims, and implementation of GA<sup>2</sup>LEN/HAEi Angioedema Centers of Reference and Excellence
Allergy 2020cited by 56position: middledoi
Hereditary angioedema in children and adolescents – A consensus update on therapeutic strategies for German‐speaking countries
Pediatric Allergy and Immunology 2020cited by 22position: middledoi
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks
The Journal of Allergy and Clinical Immunology In Practice 2019cited by 94position: middledoi
Development of the Angioedema Control Test—A patient‐reported outcome measure that assesses disease control in patients with recurrent angioedema
Allergy 2019cited by 94position: middledoi
Guideline: Hereditary angioedema due to C1 inhibitor deficiency
Allergo Journal International 2019cited by 43position: middledoi
Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks
JAMA 2018cited by 292position: middledoi
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update
World Allergy Organization Journal 2018cited by 59position: middledoi
Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data
The Journal of Allergy and Clinical Immunology In Practice 2016cited by 59position: middledoi
Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies
European Journal of Pediatrics 2012cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Markus Magerl · Humboldt-Universität zu Berlin8 papers (2012–2022)Petra Staubach · Johannes Gutenberg University Mainz6 papers (2012–2025)Emel Aygören‐Pürsün · Goethe University Frankfurt6 papers (2019–2025)Marcus Maurer · McGill University6 papers (2019–2022)Aleena Banerji · Harvard University3 papers (2021–2025)Andrea Zanichelli · University of Milan3 papers (2021–2025)Jonathan A. Bernstein · ENT and Allergy3 papers (2021–2025)William R. Lumry · The University of Texas Southwestern Medical Center3 papers (2021–2025) · 2 papers (2012–2020) · 2 papers (2012–2020)Torsten Zuberbier · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2019–2020) · 2 papers (2012–2020)Marc A. Riedl · La Jolla Institute for Immunology2 papers (2021–2021)Mauro Cancian · Bambino Gesù Children's Hospital2 papers (2025–2025)Frank Siebenhaar · Humboldt-Universität zu Berlin2 papers (2019–2020)Tamara Donoso · Charité - Universitätsmedizin Berlin2 papers (2019–2020)Paula J. Busse · Humboldt-Universität zu Berlin2 papers (2021–2025)Jens Greve · Universität Ulm2 papers (2019–2022)V. Wahn · Humboldt-Universität zu Berlin2 papers (2012–2020)Timothy Craig · Johannes Gutenberg University Mainz2 papers (2021–2025)